Jenscare Scientific (HKG:9877) filed for European regulatory approval for its JensClip transcatheter mitral valve repair system, according to a Hong Kong bourse filing Monday.
The device is designed to treat patients with severe mitral regurgitation, a condition in which the heart's mitral valve leaks.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.